Amanda Rush/LinkedIn
Dec 22, 2025, 22:34
Amanda Rush and Other Researchers Spoke with 87 Australians Affected by a Range of Blood Disorders
Haemophilia Foundation Australia shared a post on LinkedIn:
“Gene therapies are creating new hope for people with serious conditions like haemophilia. These treatments can be life-changing, but they also raise important questions: how should we pay for them, who should have access, and what happens when the long-term effects are still uncertain?
In the latest issue of National Haemophilia, Amanda Rush and other researchers spoke with 87 Australians affected by a range of blood disorders as part of a study led by the University of Sydney.
Thanks to the people and parents of children with haemophilia who participated in this research.
Read the results.”
Stay informed with latest blood disorders updates on Hemostasis Today.
-
Apr 6, 2026, 10:49Chokri Ben Lamine: Routine VTE Prophylaxis Is Not Recommended for Chronically Bedridden Patients at Home
-
Apr 6, 2026, 10:03Mohamed Sikkander Abdul Razak: Clinical Steps for Evaluating and Managing Heavy Menstrual Bleeding
-
Apr 6, 2026, 07:14Oliver Tiebel: Antiphospholipid Syndrome in Pregnancy – One of Hematology’s Most Complex Challenges
-
Apr 6, 2026, 06:25Katherine Bridge: My First Time at The EHA ReCon
-
Apr 6, 2026, 06:11Priya Prasad: Family Donations Are Not as Safe as We Usually Think
-
Apr 6, 2026, 05:48Isaac Okello: Turning Point from Reliance on Foreign Exports to Self – Reliance Through Local Production of Medical Supplies
-
Apr 6, 2026, 05:34Lena Volland: Scientific Exchange in Bleeding Disorders at the WFH 2026 World Congress
-
Apr 6, 2026, 04:46Ursula Porage Dona: Bringing the Bleeding Disorders Community Together at WFH 2026 with NNHF
-
Apr 6, 2026, 04:17Arun V J: How War Reshaped Blood Transfusion